Compare ACET & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | ALAR |
|---|---|---|
| Founded | 1947 | 2013 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 58.8M |
| IPO Year | 2017 | 2018 |
| Metric | ACET | ALAR |
|---|---|---|
| Price | $7.00 | $7.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $56.00 | $27.00 |
| AVG Volume (30 Days) | ★ 111.8K | 28.2K |
| Earning Date | 03-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.17 |
| Revenue Next Year | N/A | $30.14 |
| P/E Ratio | ★ N/A | $44.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $5.45 |
| 52 Week High | $9.05 | $18.00 |
| Indicator | ACET | ALAR |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 48.77 |
| Support Level | $6.54 | $6.34 |
| Resistance Level | $8.34 | $8.00 |
| Average True Range (ATR) | 0.44 | 0.46 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 17.94 | 47.10 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.